![Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. - Abstract - Europe PMC Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6314200/bin/nihms-1003601-f0001.jpg)
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. - Abstract - Europe PMC
![Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. - Abstract - Europe PMC Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6314200/bin/nihms-1003601-f0003.jpg)
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. - Abstract - Europe PMC
![Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1–infected individuals | Science Translational Medicine Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1–infected individuals | Science Translational Medicine](https://www.science.org/cdn-cgi/image/width=400/cms/asset/a8e8a7d1-0ec7-4971-9e97-280bb6e4a8ea/stm.2023.15.issue-687.largecover.jpg)